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Abstract: Aromatic aldoximes 1a-i undergo oxidative dehydrogenation with CrO2 to give nitrile oxides, which 
are trapped in situ by 4-methoxycinnamonitrile 2 to afford of ethyl 3,5-diaryl-4,5-dihydroisoxazole-4-
carbonitriles 3a-i in good yield.  
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I.   Introduction 
Isoxazoles and isoxazolines are very useful heterocycles in organic and heterocyclic chemistry [1].
 
Isoxazolines also serves as important building blocks for the synthesis of various biologically active molecules 
[2]. The isoxazoles are known to exhibit significant number of biological applications such as hypoglycemic, 
analgesic, anti-inflammatory and HIV-inhibitory activity [3], also found to exhibit antibacterial [4], antifungal 
[5], antioxidant [6], potent selective agonists at human cloned dopamine D4 receptors [7], COX-2 inhibitory [8], 
antinociceptive [9], anticancer [10], and antibiotic, antitumour, insecticidal activities [1,2]. They serve as 
prodrug for the anti-arithretic agent [11]. Vijay V. Dabholkar and co-workers [12] reported the synthesis and 
their antimicrobial activity of fused isoxazolines. Joshi and et al [13] reported that isoxazoles acts as potential 
antitubercular agents. 
The most convenient synthesis of isoxazoline and isoxazole ring system has been executed in the 
literature via 1, 3-dipolar cycloaddition reactions of alkenes and alkynes with nitrile oxides generated in situ 
from aldoximes [2,14].  Rai et al developed new methods for generating nitrile oxides involving oxidative 
dehydrogenation of aldoximes using oxidants such as chloramine-T and mercuric acetate [15]. Treatment of 
aldoximes with Magtreive (CrO2) in presence of dipolarophile furnished a variety of isoxazolines and isoxazoles 
as 1,3-dipoar cycloaddition products [16,17]. It was reported that nitrile oxides preferentially adds to olefinic 
C=C bond rather than C-N triple bond of acrylonitrile to form isoxazolines [18].
 
The classical method employed 
for the synthesis of isoxazolines involves 1,3-dipolar cycloaddition reactions of nitrile oxides to alkenes [19,20].  
This paper describes the successful synthesis of new 3,5-diaryl-4,5-dihydroisoxazole-4-carbonitriles via 1.3-
dipolar cycloaddition reactions 
 
II. Materials And Methods 
The chemicals/reagents used were purchased from sigma-aldrich chemicals (India) and Merck Chemicals 
(India). IR spectra were recorded on a Nujol mull on Shimadzu 8300 spectrometer. The 
1
H NMR and 
13
C NMR 
spectra were recorded on a Bruker supercon 400 MHz spectrophotometer using CDCl3 as solvent and TMS as 
an internal standard. The Chemical shifts are expressed in δ ppm. Mass spectra were obtained on Shimadzu 
LCMS-2010A spectrophotometer (chemical ionization) and the important fragments are given with the relative 
intensities in the brackets. Elemental analysis was obtained on a Thermo Finnigan Flash EA 1112 CHN 
analyser. Thin layer chromatography (TLC) was performed on a pre-coated Silica Gel sheets (HF 254, sd-fine) 
using benzene: ethyl acetate (7:2) eluent and visualization of the spots was done in iodine vapour and UV light. 
Chromatographic separations were carried out on silica gel (70-230 mesh, Merck) column using hexane: ethyl 
acetate (8:1) as eluent.  
In a general 1,3-dipolar cycloaddition reaction, a mixture of aromatic aldoximes 2,  4-methoxy 
cinnamonitrile 1,  and CrO2 in acetonitrile was stirred at 80
0
C for 2 hours. The progress of the reaction was 
monitored by TLC. After the completion of the reaction and usual work up, the reaction mixture gave one major 
spot corresponding to the product 3,5-diaryl-4,5-dihydroisoxazole-4-carbonitrile 3 in TLC, and two minor spots 
corresponding to the un-reacted precursors. The products 3 were separated by column chromatography using 
hexane:ethyl acetate (8:1 v/v) and are obtained in 52-62% yield (Scheme-1). 
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3 a) R1 = H, R2 = F, R3 = H;         b) R1 = H, R2 = Cl, R3 = H; 
   c) R1 = H, R2 = Br, R3 = H;       d) R1 = H, R2 = CN, R3 = H; 
   e) R1 = Cl, R2 = H, R3 = H;       f) R1 = NO2, R2 = H, R3 = Cl;
   g) R1 = H, R2 = OCH3, R3 = H; h) R1 = H, R2 = OCH3, R3 = OCH3; 
   i) R1 = H, R2 = H, R3 = H.
Scheme 1  
 
III. Results And Discussion 
The general synthetic pathway employed is depicted in the scheme-1. The structures of the cycloadducts 




C NMR, MS studies and elemental analysis. For instance, in IR spectra, the 
cycloadducts 3 gave the absorptions bands in the region 1650-1675 cm
-1
 for C=N (str) group which is a clear 
indication of the formation of cycloadducts, a strong and sharp absorption bands in the region 2220-2240 cm
-1
 




H NMR spectra, all substituted-4,5-dihydroisoxazole-4-carbonitriles 3 showed the peaks due to 
aromatic and substituent protons at the expected region. The consistent pattern signals due to C4-H appear as 
doublet in the region  5.00-5.29 ppm., while signals due to C5-H appears as doublet in the region  5.50-5.71 
ppm. The coupling constant (J) values calculated for C4-H and C5-H were in range 7.0-9.6 Hz, these values 
suggests that both C4-H and C5-H are cis orientation and the cycloaddition took place in cis fashion. The 
appearance of these proton signals in the downfield was expected due to the strong electron withdrawing –CN 
group and aromatic ring bonded to C4- and C5- atoms respectively, which favors the formation of cycloadducts. 
In 
13
C NMR, all products gave the signals due to aromatic and substituent carbons at the expected region. The 
signals due to newly formed C4-carbon appeared in the region c 21.2-23.6 ppm, while, C5-carbon showed the 
signals in the region c 66.59-66.94 ppm and C3-carbon showed the signals in the region c 161.3-164.7 ppm. 
The signals due to CN group carbon appear in the region c 116.2-118.0 ppm., which shows that the CN triple 
bond is unaffected during cycloaddition and is retained in the product. All substituted-4,5-dihydroisoxazole-4-
carbonitriles 3 gave significantly stable molecular ion peaks with a relative abundance ranging from 08-46% and 
base peak at (MH
+
). Further, all showed satisfactorily CHN analysis with a deviation of ±0.10% from the 
theoretically calculated values. All these observations strongly favor the formation of the cycloadducts. 
 
IV. Experimental 
4.1 Typical procedure for the preparation of 3-(4-fluorophenyl)-5-(4-methoxyphenyl)-4,5-dihydroisoxazole-
4-carbonitrile 3a: A mixture of 4-fluorobenzaldehyde oxime 2 (106mg, 0.76mmol, 1.2equiv), 3-(4-
methoxyphenyl) acrylonitrile 1 (100mg, 0.63mmol, 1.0 equiv) were dissolved in 3 ml acetonitrile. MagtrieveTM
 
(530mg, 6.31 mmol, 10 equiv) was added and the reaction mixture was stirred under heating at 80
0
C for 2 h. 
The progress of the reaction was monitored by TLC. After completion of the reaction, the reaction mixture was 
filtered through Celite bed. Magtrieve was washed with ethyl acetate (20 ml × 2). The combined filtrate was 
condensed to give the crude product, which was purified by column chromatography using hexane:ethyl acetate 
(8:1 v/v). The same procedure was used in all cases. 
3a Obtained as light yellow oil in 62% yield. IR (Nujol): 1654 cm
-1
 C=N (str), 2228 cm
-1
 CN (str). 
1
H NMR 
(CDCl3):  3.84 (s, 3H, OCH3), 5.29 (d, 1H, J=7.2Hz, C4-H), 5.71 (d, 1H, J=8.4Hz, C5-H), 6.90-6.93 (dd, 2H, 
Ar-H), 6.93-6.95 (dd, 2H, Ar-H), 7.38-7.40 (dd, 2H, Ar-H), 7.78-7.80 (dd, 2H, Ar-H). 
13
C NMR (CDCl3):  21.2 
(1C, 4-C), 55.1 (1C, OCH3), 66.5 (1C, 5-C), 114.1-114.5 (2C, Ar-C), 115.6-115.9 (2C, Ar-C), 116.2 (1C, CN), 
128.4-128.7 (2C, Ar-C), 129.2-129.5 (2C, Ar-C), 130.3 (1C, Ar-C), 130.6 (1C, Ar-C), 149.6 (1C, Ar-C), 161.3 
(1C, 3-C), 161.7 (1C, Ar-C). MS (relative abundance) m/z: 297(MH
+
, 100), 270 (32), 238 (20), 174 (16), 157 
(44). Anal. Cacld. for C17H13FN2O2, C, 68.91, H, 4.42, N, 9.45%; Found: C, 68.85, H, 4.46, N, 9.37%.  
4.2 Synthesis of 3-(4-Chlorophenyl)-5-(4-methoxyphenyl)-4,5-dihydroisoxazole-4-carbonitrile 3b: Obtained 
from 4-methoxy cinnamonitrile 1 (100mg, 0.63mmol, 1.0equiv) and 4-chlorobenzaldehyde oxime 2 (118mg, 
0.76mmol, 1.2equiv), as a light yellow oil in 54% yield. IR (Nujol): 1650 cm
-1
 C=N (str), 2220 cm
-1
 CN (str). 
1
H 
NMR (CDCl3):  3.84 (s, 3H, OCH3), 5.28 (d, 1H, J=9.0Hz, C4-H), 5.70 (d, 1H, J=9.6Hz, C5-H), 6.91-6.92 (dd, 
2H, Ar-H), 6.93-6.94 (dd, 2H, Ar-H), 7.38-7.40 (dd, 2H, Ar-H), 7.78-7.79 (dd, 2H, Ar-H). 
13
C NMR (CDCl3):  
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21.4 (1C, 4-C), 55.2 (1C, OCH3), 66.8 (1C, 5-C), 114.2-114.4 (2C, Ar-C), 115.7-115.9 (2C, Ar-C), 116.6 (1C, 
CN), 128.5-128.7 (2C, Ar-C), 129.2-129.4 (2C, Ar-C), 130.7 (1C, Ar-C), 130.9 (1C, Ar-C), 150.2 (1C, Ar-C), 
161.7 (1C, 3-C), 162.0 (1C, Ar-C). MS (relative abundance) m/z: 313 (MH
+
, 100), 286 (28), 254 (24), 174 (18), 
157 (42). Anal. Cacld. for C17H13ClN2O2, C, 65.29, H, 4.19, N, 8.96%; Found: C, 65.19, H, 4.18, N, 8.89%. 
 
4.3   Synthesis of 3-(4-Bromophenyl)-5-(4-methoxyphenyl)-4,5-dihydroisoxazole-4-carbonitrile 3c: Obtained 
from 4-methoxy cinnamonitrile 1 (100mg, 0.63mmol, 1.0equiv) and 4-bromobenzaldehyde oxime 2 (152mg, 
0.76mmol, 1.2equiv), as a pale yellow oil in 52% yield. IR (Nujol): 1675 cm
-1
 C=N (str), 2240 cm
-1
 CN (str). 
1
H 
NMR (CDCl3):  3.86 (s, 3H, OCH3), 5.19 (d, 1H, J=7.6Hz, C4-H), 5.62 (d, 1H, J=8.2Hz, C5-H), 6.91-6.93 (dd, 
2H, Ar-H), 6.93-6.95 (dd, 2H, Ar-H), 7.38-7.41 (dd, 2H, Ar-H), 7.77-7.79 (dd, 2H, Ar-H). 
13
C NMR (CDCl3):  
22.3 (1C, 4-C), 55.6 (1C, OCH3), 66.9 (1C, 5-C), 114.1-114.3 (2C, Ar-C), 116.8 (1C, CN), 125.1 (1C, Ar-C), 
126.1-126.4 (2C, Ar-C), 128.5-128.7 (2C, Ar-C), 130.1-130.3 (2C, Ar-C), 131.9 (1C, Ar-C), 133.6 (1C, Ar-C), 








Br 66), 332 
(19), 330 (28), 300 (08), 298 (25), 174 (22), 157 (46). Anal. Cacld. for C17H13BrN2O2, C, 57.16, H, 3.67, N, 
7.84%; Found: C, 57.10, H, 3.70, N, 7.78%. 
 
4.4   Synthesis of 3-(4-Cyanophenyl)-5-(4-methoxyphenyl)-4,5-dihydroisoxazole-4-carbonitrile 3d: Obtained 
from 4-methoxy cinnamonitrile 1 (100mg, 0.63mmol, 1.0equiv) and 4-cyanobenzaldehyde oxime 2 (111mg, 
0.76mmol, 1.2equiv), as a colourless oil in 58% yield. IR (Nujol): 1658 cm
-1
 C=N (str), 2234 cm
-1
 CN (str). 
1
H 
NMR (CDCl3):  3.85 (s, 3H, OCH3), 5.11 (d, 1H, J=8.0Hz, C4-H), 5.54 (d, 1H, J=8.2Hz, C5-H), 6.92-6.92 (dd, 
2H, Ar-H), 7.22-7.24 (dd, 2H, Ar-H), 7.65-7.67 (dd, 2H, Ar-H), 7.98-7.99 (dd, 2H, Ar-H). 
13
C NMR (CDCl3):  
23.5 (1C, 4-C), 55.8 (1C, OCH3), 66.9 (1C, 5-C), 114.4-114.6 (2C, Ar-C), 115.6 (1C, Ar-C), 116.9 (1C, CN), 
118.0 (1C, CN), 126.8-126.9 (2C, Ar-C), 129.0-129.1 (2C, Ar-C), 131.0-131.2 (2C, Ar-C), 132.3 (1C, Ar-C), 
136.7 (1C, Ar-C), 159.7 (1C, Ar-C), 163.2 (1C, 3-C). MS (relative abundance) m/z: 304 (MH
+
, 100), 277 (21), 
245 (30), 174 (23), 157 (41). Anal. Cacld. for C18H13N3O2, C, 71.28, H, 4.32, N, 13.85%; Found: C, 71.21, H, 
4.24, N, 13.79%. 
 
4.5   Synthesis of 3-(2-Chlorophenyl)-5-(4-methoxyphenyl)-4,5-dihydroisoxazole-4-carbonitrile 3e: Obtained 
from 4-methoxy cinnamonitrile 1 (100mg, 0.63mmol, 1.0equiv) and 2-chlorobenzaldehyde oxime 2 (118mg, 
0.76mmol, 1.2equiv), as a colorless oil in 55% yield. IR (Nujol): 1668 cm
-1
 C=N (str), 2235 cm
-1
 CN (str). 
1
H 
NMR (CDCl3):  3.87 (s, 3H, OCH3), 5.00 (d, 1H, J=8.4Hz, C4-H), 5.50 (d, 1H, J=8.6Hz, C5-H), 6.91-6.93 (dd, 
2H, Ar-H), 7.23-7.24 (dd, 2H, Ar-H), 7.39-7.41 (dd, 2H, Ar-H), 7.669-7.681 (dd, 2H, Ar-H). Anal. Cacld. for 
C17H13ClN2O2, C, 65.29, H, 4.19, N, 8.96%; Found: C, 65.22, H, 4.22, N, 8.89%. 
 
4.6 Synthesis of 3-(5-Chloro-2-nitrophenyl)-5-(4-methoxyphenyl)-4,5-dihydroisoxazole-4-carbonitrile 3f: 
Obtained from 4-methoxy cinnamonitrile 1 (100mg, 0.63mmol, 1.0equiv) and 5-chloro-2-nitrobenzaldehyde 
oxime 2 (152mg, 0.76mmol, 1.2equiv), as a light yellow oil in 53% yield. IR (Nujol): 1668 cm
-1
 C=N (str), 2230 
cm
-1
 CN (str). 
1
H NMR (CDCl3):  3.79 (s, 3H, OCH3), 5.12 (d, 1H, J=8.1Hz,  C4-H), 5.51 (d, 1H, J=9.0Hz, C5-
H), 6.92-6.93 (dd, 2H, Ar-H), 7.23-7.24 (dd, 2H, Ar-H), 7.70 (dd, 1H, Ar-H), 8.11 (d, 1H, Ar-H), 8.20 (dd, 1H, 
Ar-H). 
13
C NMR (CDCl3):  23.6 (1C, 4-C), 55.8 (1C, OCH3), 66.8 (1C, 5-C), 114.3-114.5 (2C, Ar-C), 116.7 
(1C, CN), 124.1 (1C, Ar-C), 127.0-127.2 (2C, Ar-C), 130.3 (1C, Ar-C), 131.2 (1C, Ar-C), 132.8 (1C, Ar-C), 
132.9 (1C, Ar-C), 136.1 (1C, Ar-C), 140.1 (1C, Ar-C), 159.9 (1C, Ar-C), 164.2 (1C, 3-C). MS (relative 








Cl, 33), 333 (08), 331 (22), 299 (34), 174 (22), 157 (40). 
Anal. Cacld. for C17H12ClN3O4, C, 57.07, H, 3.38, N, 11.75%; Found: C, 57.00, H, 3.43, N, 11.78%. 
 
4.7 Synthesis of 3,5-Bis(4-methoxyphenyl)-4,5-dihydroisoxazole-4-carbonitrile 3g: Obtained from 4-methoxy 
cinnamonitrile 1 (100mg, 0.63mmol, 1.0equiv) and 4-methoxybenzaldehyde oxime 2 (115mg, 0.76mmol, 
1.2equiv), as a colourless oil in 60% yield. IR (Nujol): 1655 cm
-1
 C=N (str), 2225 cm
-1
 CN (str). 
1
H NMR 
(CDCl3):  3.80 (s, 3H, OCH3), 3.81 (s, 3H, OCH3), 5.13 (d, 1H, J=8.1Hz, C4-H), 5.51 (d, 1H, J=8.8Hz, C5-H), 
6.92-6.93 (dd, 2H, Ar-H), 6.99-6.70 (dd, 2H, Ar-H), 7.22-7.23 (dd, 2H, Ar-H), 7.74-7.75 (dd, 2H, Ar-H). 
13
C 
NMR (CDCl3):  23.5 (1C, 4-C), 55.7 (1C, OCH3), 55.8 (1C, OCH3), 66.8 (1C, 5-C), 114.3-114.4 (2C, Ar-C), 
116.6 (1C, CN), 124.2 (1C, Ar-C), 127.1-127.2 (2C, Ar-C), 130.2 (1C, Ar-C), 131.2 (1C, Ar-C), 132.9 (1C, Ar-
C), 133.0 (1C, Ar-C), 136.0 (1C, Ar-C), 140.1 (1C, Ar-C), 159.9 (1C, Ar-C), 164.2 (1C, 3-C). MS (relative 
abundance) m/z: 309 (MH
+
, 100), 282 (36), 250 (32), 174 (27), 157 (42). Anal. Cacld. for C18H16N2O3, C, 70.12, 
H, 5.23, N, 9.09%; Found: C, 70.06, H, 5.26, N, 9.10%. 
 
4.8 Synthesis of 3-(3,4-Dimethoxyphenyl)-5-(4-methoxyphenyl)-4,5-dihydroisoxazole-4-carbonitrile 3h: 
Obtained from 4-methoxy cinnamonitrile 1 (100mg, 0.63mmol, 1.0equiv) and 3,4-dimethoxybenzaldehyde 
oxime 2 (138mg, 0.76mmol, 1.2equiv), as a colourless oil in 61% yield. IR (Nujol): 1672 cm
-1





H NMR (CDCl3):  3.81 (s, 6H, OCH3), 3.81 (s, 3H, OCH3), 5.12 (d, 1H, J=8.5Hz, C4-H), 5.52 
(d, 1H, J=9.2Hz, C5-H), 6.92-6.93 (dd, 2H, Ar-H), 6.99 (dd, 1H, Ar-H), 7.23-7.24 (dd, 2H, Ar-H), 7.30 (s, 1H, 
Ar-H), 7.40 (dd, 1H, Ar-H). 
13
C NMR (CDCl3):  23.4 (1C, 4-C), 55.8 (1C, OCH3), 55.8 (1C, OCH3), 55.8 (1C, 
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OCH3), 66.8 (1C, 5-C), 112.1 (1C, Ar-C), 114.2-114.3 (3C, Ar-C), 116.6 (1C, CN), 121.2 (1C, Ar-C), 127.1-
127.3 (3C, Ar-C), 148.7 (1C, Ar-C), 149.1 (1C, Ar-C), 150.4 (1C, Ar-C), 158.9 (1C, Ar-C), 164.2 (1C, 3-C). 
MS (relative abundance) m/z: 339 (MH
+
, 100), 312 (19), 280 (33), 174 (26), 157 (45). Anal. Cacld. for 
C19H18N2O4, C, 67.44, H, 5.36, N, 8.28%; Found: C, 67.38, H, 5.32, N, 8.21%. 
 
4.9   Synthesis of 5-(4-Methoxyphenyl)-3-phenyl-4,5-dihydroisoxazole-4-carbonitrile 3i: Obtained from 4-
methoxy cinnamonitrile 1 (100mg, 0.63mmol, 1.0equiv) and benzaldehyde oxime 2 (92mg, 0.76mmol, 
1.2equiv), as a colourless oil in 56% yield. IR (Nujol): 1670 cm
-1
 C=N (str), 2235 cm
-1
 CN (str). 
1
H NMR 
(CDCl3):  3.82 (s, 3H, OCH3), 5.13 (d, 1H, J=9.0Hz, C4-H), 5.53 (d, 1H, J=8.5Hz, C5-H), 6.91-6.93 (dd, 2H, 
Ar-H), 7.20-7.22 (dd, 2H, Ar-H), 7.56-7.78 (m, 5H, Ar-H). 
13
C NMR (CDCl3):  23.4 (1C, 4-C), 55.8 (1C, 
OCH3), 66.7 (1C, 5-C), 114.3 (2C, Ar-C), 116.6 (1C, CN), 127.0 (2C, Ar-C), 128.2 (2C, Ar-C), 128.4 (2C, Ar-
C), 131.1 (1C, Ar-C), 133.0 (1C, Ar-C), 133.6 (1C, Ar-C), 159.0 (1C, Ar-C), 164.7 (1C, 3-C). MS (relative 
abundance) m/z: 279 (MH
+
, 100), 252 (22), 220 (30), 174 (20), 157 (38). Anal. Cacld. for C17H14N2O2, C, 73.37, 
H, 5.07, N, 10.07%; Found: C, 73.30, H, 5.01, N, 10.02%. 
 
V. Conclusion 
The successful synthesis of new compounds with the use of CrO2 as catalytic dehydrogenating agents 
validates the significance of this study. However, the modification in the procedure for improving the yield of 
the products remains of interest. 
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